NCT06203327Recruiting
Atrophic Gastritis Predicts the Risk of Gastric Cancer
Atrophic Gastritis Predicts the Risk of Gastric Cancer: a Prospective Cohort Study
Source: ClinicalTrials.gov · Last updated 30 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Despite declining incidence rates, gastric cancer (GC) ranks the fourth leading cause of cancer-related mortality and the fifth most common cancer worldwide, with the highest incidence reported in Eastern Asia. The 5-year overall survival rate of early GC exceeds 90%, which was well above advanced GC. Most intestinal-type GCs follow the Correa cascade-inflammation,atrophy, intestinal metaplasia (IM), dysplasia and subsequent carcinoma. The presence of gastric mucosal atrophy and intestinal metaplasia are important risk factors for GC. The purpose of this study was to investigate the incidence of GC attributed to atrophic gastritis in a region with high incidence of GC.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2042 (estimated)
- First submitted
- 25 Dec 2023
- Start date
- 15 Dec 2023
- Primary completion date
- 31 Dec 2034
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06203327
What you commit to
- Study type: Observational
- Planned participants: 2042
- From 15 Dec 2023 to the primary completion date, 31 Dec 2034
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- history of gastrectomy
- severe systemic diseases or malignancy
Age
- under 18 or over 80 years old
Who the study is looking for
- Ability and willingness to participate in the study and to sign and give informed consent
- Biopsies were collected based on the recommendation of updated Sydney system
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Renji Hospital, School of Medicine, Shanghai Jiao Tong University Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.